Health Insurance Shock: South Korea froze the 2027 national health insurance premium rate at 7.19% despite the fund expected to post its first deficit in six years, citing reserves and recent revenue gains. Aging & Pensions: Basic pension recipients in South Korea topped 7 million for the first time, but the coverage rate fell for a fourth straight year as the 65+ population grew faster than the recipient pool. Biopharma Strategy: The government plans a “K-CRDMO” push to strengthen biopharmaceutical research-to-production capacity, with early focus likely on ADCs and cell & gene therapy. Cancer Support: Ralph Lauren will partner with the National Cancer Center of Korea to open a patient and family recovery center for proton therapy in 2028. Workplace Health Equity: Human Rights Watch warns women in South Korea face systemic gender and age discrimination at work that harms physical and mental health, including widening pension gaps. Food & Wellness Trend: Musinsa is expanding into beauty retail with a new offline push, signaling continued growth in health-adjacent consumer categories. Public Health Research: KAIST reports a vitamin A derivative (ATRA) may help prevent immune cell exhaustion in brain tumors and boost anti-PD-1 immunotherapy effects.